Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sequella, Maxwell sign pact to develop, commercialize TB drug
Jointly discovered by scientists at Sequella and the National Institute of Allergy and Infectious Diseases (NIAID), SQ109 is currently being investigated in Phase 2 efficacy studies in TB
Jointly discovered by scientists at Sequella and the National Institute of Allergy and Infectious Diseases (NIAID), SQ109 is currently being investigated in Phase 2 efficacy studies in TB
While MSD brings the scientific excellence of the compound to the partnership, Sun Pharma brings its expertise in the marketing of drugs in the relevant therapeutic areas across
Depakote delayed-release tablets falls under the central nervous system (CNS) therapeutic category as a treatment for the manic episodes associated with bipolar disorder. They are indicated as monotherapy
Mircera Injection Syringe uses epoetin beta (genetical recombination) which is chemically combined with a single molecule of linear methoxy polyethylene glycol (PEG). It has a longer serum half-life
The increase was driven primarily by the continued growth of Tysabri (natalizumab) revenues, which increased 15% to $251m, and Avonex (interferon beta-1a) revenues, which increased 8% to $642m.
Bayer will manufacture the bulk drug substance at its Berkeley, California clinical manufacturing center to support Phase 1 clinical testing planned to commence in 2012. OncoMed Pharma president
Developed by Teikoku Pharma USA, a subsidiary of Teikoku Seiyaku, the Aricept Patch is a weekly transdermal patch intended to provide an alternative formulation for Alzheimer’s patients. Teikoku
The product candidates are currently in early- to mid-stage clinical development for a variety of diseases. They target several novel pathways of disease by inhibiting the activity of
Sage Healthcare Division, which serves more than 400,000 healthcare professionals, including 80,000 physicians in North America, will make its ONC-ATCB certified Sage Intergy Meaningful Use Edition available to
Spectrum Pharma’s Fusilev injection has been approved as the rescue after high-dose methotrexate therapy in osteosarcoma. Fusilev is also indicated to diminish the toxicity and counteract the effects